![Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide...](https://static.cymitquimica.com/products/3D/img/JMB71436.png "Haga clic para ampliar")
Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,tetrahydrate
CAS: 934714-36-0
Ref. 3D-JMB71436
| 50mg | A consultar | ||
| 100mg | A consultar |
Información del producto
Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,tetrahydrate is a prodrug of strontium that is hydrolyzed by esomeprazole and omeprazole to release the active form. Strontium has been shown to be effective in treatment of bowel disease. Strontium inhibits the production of prostaglandins and leukotrienes, leading to decreased inflammation in the gastrointestinal tract. It also has a therapeutic effect on reflux disease. Strontium can cause drug interactions with other drugs metabolized by cytochrome P450 enzymes (e.g., esomeprazole) or that inhibit gastric acid secretion (e.g., omeprazole).
Propiedades químicas
Consulta técnica sobre: 3D-JMB71436 Strontium,5-methoxy-2-[(S)-(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]benzimidazol-1-ide,tetrahydrate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
